Navigation Links
LeMaitre Vascular to Start Italian Sales Force
Date:10/1/2007

hat we have continued in the U.K., Japan, the Benelux, Austria, Sweden, and this year France," said George W. LeMaitre, Chairman and CEO of LeMaitre Vascular. "This is the natural conclusion to a long and mutually productive relationship with Serom."

LeMaitre Vascular expects to record a charge of approximately $1.1 million in Q3 2007 as a result of this transaction.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Statements in this press release regarding the Company's business that are not historical facts may be "forward-looking statements" that involve risks and uncertainties. Specifically, statements regarding the Company's financial guidance and its operational objectives, and the Company's ability to hire a direct sales organization, attain higher gross margins and develop closer relationships with Italian vascular surgeons, are forward-looking statements involving risks and uncertainties. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks and uncertainties that could cause actual results to differ from the results predicted and include, but are not limited to, the Company's ability to successfully retain Serom's customer base for LeMaitre Vascular products, the Company's ability to retain a material portion of Serom's sales agent network, the Company's ability to expand its sales force in Italy, risks related to product demand and market acceptance of the Company's products, the significant competition the Company faces from other companies, technologies and alternative medical procedures, the Company's ability to expand its product offerings through internal development or acquisition, the Company's ability to realize the anticipated benefits of its acquisitions, disruption at the Company's single manufacturing facility, the Company's lack of experience with and gene
'/>"/>

SOURCE LeMaitre Vascular, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. “Don’t fear long haul flights!” Vascular surgeon tells travelrs
2. People who fight wars may be at high risk of cardiovascular disease
3. Abbott Laboratories to buy Biocompatibles cardiovascular stent business
4. High iron levels may cause Cardiovascular Disease in women
5. Erectile dysfunction (ED) signals vascular disease
6. Drug Effective for Vascular Dementia
7. Air Pollution said To Increase Risk of Cardiovascular Disease
8. Link Between Alcohol Consumption And Cardiovascular Disease
9. Beer Found To Be Effective In Fighting Cardiovascular Disease
10. New Guidelines Found To Benefit Cardiovascular Treatment
11. Women With A High-Risk Of Cardiovascular Disease Under treated
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)... OneMedPlace announced today the pan...uo; finance conference, to be held January 13-14, ...tel. Panels will address the “drivers and di...dtech sectors: Orthopedics and Spine; Central Nerv...gy and Sexual Health; Advances in Surgery; Wound C...
(Date:12/4/2008)... Improved Performance and New Produc... Clifton Park, NY (Vocus) De... of integrated e-learning solutions for healthcare...and part of Cengage Learning, is pleased to annou...istrator, version 7.1 (LA7.1), including SCORM (Sh...
(Date:12/4/2008)... , Boston,...stories of 2008 may not be as funny as David Lette...ke a difference for long-term health. Here are thi... the Harvard Health Letter:, , , , ,1. Blood suga...suit of low blood sugar levels is probably not the...
(Date:12/4/2008)...Calif., Dec. 4 Kenneth K...ornia,s health care industry, has been named Presi...lthcare Holdings, Inc., effective immediately. IH...Orange County, California: Western Medical Center ...hapman Medical Center and Coastal Communities Hosp...
Breaking Medicine News(10 mins):Health News: OneMedPlace announces panels for "OneMedForum 2009: Disrupters and Drivers in Eight Areas of Medical Technology" -- CEOs and investors to meet in unique format of focused sessions 2Health News:NetLearning Releases Learning Administrator 7.1 for Online Professional Healthcare Training 2Health News:NetLearning Releases Learning Administrator 7.1 for Online Professional Healthcare Training 3Health News:The Top 10 Health Stories of 2008, from the Harvard Health Letter 2Health News:The Top 10 Health Stories of 2008, from the Harvard Health Letter 3Health News:The Top 10 Health Stories of 2008, from the Harvard Health Letter 4Health News:Integrated Healthcare Holdings, Inc. Announces New Chief Executive Officer 2
... by which an breastfeeding women who is also overw...at the overweight women who are breastfeeding and ...ir target by decreasing the amount of sweetened dr... in their diet. They have also recommended that sh...
...ok had as of yesterday cleared the three people wh... the deadly H5N1 virus// from the bird flu watch-l...om common flu. Confirming that the three patients... bird flu were suffering from influenza, Dr Prat B...
...Vermont say that drinking cherry juice may be the ... number of antioxidant// and anti-inflammatory com... conditions. In one study The British Journal of ... men and women who ate 45 cherries per day had low...
...new education bill in the state that allows privat... non-resident Indian (NRI) students//. Lok Sabha m...f Daily News newspaper, described the new bill as ...ght it. He was in Bahrain to attend a memorial me...
Other Medicine News:Health News:Diet & Exercise regime Not Harmful For Overweight, Lactating Mothers Or their Infants 2
(Date:12/4/2008)...December 4 Biopharmaceutical compa...essfully completed treatment of the,last patient ...), a donor,lymphocyte cell based product, is unde...Disease (GvHD) and allow early immune reconstituti...tion. Nineteen end stage blood cancer,patients we...
(Date:12/4/2008)...tive TLR8 Agonist to Advance to Clinical Trials ,... Pharmaceuticals, Inc., a biopharmaceutical compan...ceptor 8 (TLR8) agonists for the treatment of canc... today that it has initiated a Phase I clinical tr...treatment of cancer. The multi-center clinical tr...
(Date:12/4/2008)...Dec. 4 NovaRx Corporation announce....D to the position of President and Chief Operatin... than 25 years experience in drug discovery and a ...maceutical discovery and development. He also has...companies developing pioneering new technologies. ...
(Date:12/4/2008)...lif.,Dec. 4 Velos, Inc., the recog...als management information systems, today announce...sity of Kansas Medical Center (KU Medical Center)... a comprehensive, system-wide roll-out that suppor...linical information needs of the institution,s cli...
Breaking Medicine Technology:Kiadis Pharma Announces Positive Clinical Results for ATIR(TM) in Mismatched Bone Marrow Transplantations 2VentiRx Pharmaceuticals Commences Phase I Clinical Trial of VTX-2337, a Novel TLR8 Agonist for the Treatment of Oncology 2NovaRx Appoints Industry Veteran as President and COO 2NovaRx Appoints Industry Veteran as President and COO 3University of Kansas Medical Center to Deploy Velos eResearch System-Wide 2University of Kansas Medical Center to Deploy Velos eResearch System-Wide 3Statement by the American Egg Board and Egg Nutrition Center on AJCN Study on Egg Consumption 16426 1Statement by the American Egg Board and Egg Nutrition Center on AJCN Study on Egg Consumption 16426 2Statement by the American Egg Board and Egg Nutrition Center on AJCN Study on Egg Consumption 16426 3Baxters V Link Luer Activated Device With VitalShield Protective Coating Now Available For Hospitals 4501 1Baxters V Link Luer Activated Device With VitalShield Protective Coating Now Available For Hospitals 4501 2Baxters V Link Luer Activated Device With VitalShield Protective Coating Now Available For Hospitals 4501 3Baxters V Link Luer Activated Device With VitalShield Protective Coating Now Available For Hospitals 4501 4UD researchers discover novel gene toggles in worlds top food crop 2835 1UD researchers discover novel gene toggles in worlds top food crop 2835 2UD researchers discover novel gene toggles in worlds top food crop 2835 3Stenting as Good as Surgery for Stroke Prevention 16422 1Stenting as Good as Surgery for Stroke Prevention 16422 2
...ortly, CARMIEL, Israel, April 18, 2007 /PRNewswire...ay announced that it has received,written notice f...,(FDA) that it may initiate a Phase III clinical t...idate, prGCD, a proprietary plant,cell expressed r...,for the treatment of Gaucher Disease, a lysosomal...
...eting Also Showed No,Significant Impact on Weight ...ay 21, 2007 /PRNewswire-FirstCall/ --,Findings fro...,effect of desvenlafaxine succinate on anxious sym... with major depressive disorder,(MDD) -- as well a...ect of desvenlafaxine succinate on weight change i...
Other Medicine Technology:Protalix BioTherapeutics, Inc. Receives Approval from the FDA to,Initiate a Phase III Clinical Trial of prGCD 2Protalix BioTherapeutics, Inc. Receives Approval from the FDA to,Initiate a Phase III Clinical Trial of prGCD 3Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo 2Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo 3Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo 4Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo 5Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo 6
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
Medicine Products: